$VCNX 3 SEC Filings

Filed On	Filing
14 Mar 2024	Form 3: Sanchez Jill, Interim CFO
21 May 2021	Form 3: Evans Elizabeth E., Chief Operating Officer Holds 9,600 shares of Common Stock
01 Sep 2020	Form 3: Scala Robert, Chief Commercial Officer No securities owned
18 May 2020	Form 3: Stecyk Chrystyna Bedrij, Director No securities owned
18 Jan 2019	Form 3: Crane Alan L, Director
09 Aug 2018	Form 3: Leonard John E., SVP, Development Holds 1,014 shares of Common Stock
09 Aug 2018	Form 3: Antibody Investments Llc, 10% owner and 1 other
09 Aug 2018	Form 3: Yanni Barbara, Director
09 Aug 2018	Form 3: Watkins Raymond E., SVP & Chief Operating Officer Holds 7,850 shares of Common Stock
09 Aug 2018	Form 3: Van Strydonck, Gerald E., Director
09 Aug 2018	Form 3: Smith Ernest S., SVP, Research & CSO Holds 16,000 shares of Common Stock
09 Aug 2018	Form 3: Royer Scott E., Chief Financial Officer
09 Aug 2018	Form 3: Manian Bala S, Director No securities owned
09 Aug 2018	Form 3: Frieberg Jacob B., Director
09 Aug 2018	Form 3: Goater Jeff, Director Holds 300 shares of Common Stock
09 Aug 2018	Form 3: Berlin Alejandro M., Director
09 Aug 2018	Form 3: Zauderer Maurice, Director and 1 other Holds 84,201 shares of Common Stock
09 Aug 2018	Form 3: Friedberg Albert, Director and 1 other Holds 444,294 shares of Common Stock

Comments